One Health Approach to Emerging Viral Infections

It is in this struggle that humanity engages in continuous struggles against emerging viral infections, where interdependence most strikingly shows up between human, animal, and environmental health. The way forward in the face of the complex challenges brought about by zoonotic diseases can potentially be offered by a more wholesome, comprehensive One Health approach. The One Health framework could trigger transdisciplinary and intersectoral collaboration, enabling enhancements in prevention, detection, and response to infectious diseases of possible zoonotic origin and thereby enhancing global public health security. This paper reviews and discusses the contribution of a “One Health” approach to fighting emerging viral infections. It aims at providing key points and updates from recent research on the subject at hand, understanding the “One Health” concept.

The concept of one health comes from an appreciation of the fact that human health, animal health, and the environment cannot be separated. One Health is, therefore, multi-disciplinary, integrating human medicine with veterinary medicine together with environmental science in devising effective solutions in cases where challenges are at the interface of all these. Added to that, this integrative approach is further driven home by the fact that the viruses causing COVID-19, SARS, and MERS are of zoonotic origin and have been shown to be capable of producing high levels of morbidity and mortality in humans.

Epidemiologic research remains the keystone to the One Health picture in monitoring, understanding the distribution of infectious diseases, and detecting trends, along with alerting risk factors for the spread of infectious diseases. According to several works, the origin of most emerging zoonoses is usually in wildlife, and only after hosts act as intermediates does the path reach humans—either by direct or aerosol contact. For example, COVID-19 is caused by the SARS-CoV-2 virus, presumed to originate from bats and probably entering humans through an intermediate host, like pangolins. An epidemiology study about these diseases presents knowledge for targeted intervention in preventive measures.

The only way to determine methods of treatment and prevention was to investigate how these zoonotic viruses interact with host organisms and what their pathogenesis is. SARS-CoV and MERS-CoV are now known to unveil the intricate mechanisms by which the virus adapts to human hosts; shortly afterward, it can evade the immune responses such hosts develop. The surface proteins on this virus are called spike proteins and are accountable for infecting human cells. Such information regarding the structure and function of these proteins can be applied by scientists in developing vaccines or antiviral therapy that would block the entry and self-replication of viruses.

Yearwise Publication Trend on viral infections

Find publication trends on relevant topics

Surveillance and Follow-up: Role

Surveillance and monitoring systems are integral parts of the One Health approach. It realizes how early the detection of emerging pathogens and the response to contain outbreaks can be done. Advanced technologies, such as next-generation genetic sequencing and computational modeling, will further increase the capability to identify and track viral mutations and the spread of those mutations. For instance, still newly discovered variants of the SARS-CoV-2 virus have come to be very helpful in the context of forming public health strategies and ways of developing vaccines. Environmental Factors and Viral Emergence Among other conditions, the environment plays the most crucial role in the emergence and transmission of zoonotic diseases.

Destruction of habitats and human incursion into the habitats of wild animals increase the probabilities for the interaction of humans with animals, thus increasing the spillover possibilities for viruses. It will further change the ecology and distribution of vectors, which may include dengue, zika, and chikungunya, some of the diseases that are transmitted through arboviral transmission. This will simultaneously ignite the spread and ecology of the vectors transmitting arboviral diseases like dengue, zika, and chikungunya. It will effectively be checked by adopting proper and sustainable sets of practices and policies for related environmental factors; hence, this will reduce future pandemics. 

One Health Case Study: COVID-19: A Global Problem

The COVID-19 pandemic has been a rude awakening to the necessity of a one-health approach. This pathogen spread faster than anything seen before and infected a huge number of people, stressing health systems to the extent that it emphasized the need to coordinate actions through government sectors to contain the pathogen. Such measures include not only the oversight of the wild animal trade but also habitat protection and biosecurity practices as they pertain to livestock farming. Some of these critical measures can prevent future zoonotic SARS.

SARS and MERS: what we have learned

Surely, after the horrible events of 2002 about SARS and 2012 about MERS, it has given us insight toward the well-management of zoonotic illness. Besides both of these, other than having an animal origin, SARS was started by bats with  cats, and MERS was started by camels. It was also a fact that both caused grave respiratory illnesses in human beings. Therefore, the detection of animal models and studies at the host-pathogen interfaces were highly useful in the course of the diseases and in the development of countermeasures. These lessons and experiences informed the more significant part of the strategies that were set within the present combat against COVID-19.

Perspective on Mosquito-borne Viral Diseases: The One Health

These are all mosquito-borne viruses hailing from the tropical islands, but with distinct ecological surroundings and socio-demographic change combined, the most predisposing place for virus transmission.

This would only further reiterate, from the One Health point of view, the need for integrated vector management, environmental modification, and community engagement in controlling the spread of viruses.

Recent Publications on viral infections

Find publications on relevant topics

Vaccine Development Update

No less an example of the ability to work quickly under the One Health approach is the rapid development of vaccines against such emerging viral diseases. At the forefront of those taking place, only a few would be genetic sequencing, synthetic biology, and platform technologies right there for accelerating that process. It’s very much put across that, in the case of COVID-19, mRNA vaccines put volcanology on a different curve. These technologies now enable fast vaccine design and production and are hence a critical tool in combating rapidly emerging infectious diseases.

Future Perspectives

“So an interdisciplinary approach involving various stakeholder collaborations from the government, healthcare providers, veterinarians, environmentalists, and the public is very key,” he said. Increasing the culture of conducting interdisciplinary research and action will be essential for responding to the complex challenges of zoonotic diseases. Of note, investing in education and traineeships where One Health concepts are propagated will also be important in setting up a resilient world health system.

Conclusion

The One Health approach offers an integrative framework for dealing with the difficult challenges of emerging viral infections, and it’s a way forward for the prevention, detection, and response to zoonotic diseases. It recognizes the intrinsic interdependence between humans, animals, and their environments in the field of surveillance and research while applying interventions. Integrated surveillance and research are indispensable in meeting future pandemics.

References

  1. Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, Chen Z, Ding N, Li W, Huang H, Zhang L, Li X, Xue X. New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention. Front Cell Dev Biol. 2020 May 22;8:410. doi: 10.3389/fcell.2020.00410. PMID: 32574318; PMCID: PMC7256189.
  2. Zhao Y, Cui C, Zhang K, Liu J, Xu J, Nisenbaum E, Huang Y, Qin G, Chen B, Hoffer M, Blanton SH, Telischi F, Hare JM, Daunert S, Shukla B, Pahwa SG, Jayaweera DT, Farmer PE, Del Rio C, Liu X, Shu Y. COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection. Front Public Health. 2020 May 19;8:205. doi: 10.3389/fpubh.2020.00205. PMID: 32574296; PMCID: PMC7248242.
  3. Ali S, Noreen S, Farooq I, Bugshan A, Vohra F. Risk Assessment of Healthcare Workers at the Frontline against COVID-19. Pak J Med Sci. 2020 May;36(COVID19-S4):S99-S103. doi: 10.12669/pjms.36.COVID19-S4.2790. PMID: 32582323; PMCID: PMC7306961.
  4. Shi Q, Zhou Q, Wang X, Liao J, Yu Y, Wang Z, Lu S, Ma Y, Xun Y, Luo X, Li W, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y, Li Q, Yang K, Guan Q; COVID-19 Evidence and Recommendations Working Group. Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis. Ann Transl Med. 2020 May;8(10):624. doi: 10.21037/atm-20-3301. PMID: 32566561; PMCID: PMC7290634.
  5. Liu Z, Gao L, Xue C, Zhao C, Liu T, Tia A, Wang L, Sun J, Li Z, Harding D. Epidemiological Trends of Coronavirus Disease 2019 in Sierra Leone From March 2020 to October 2021. Front Public Health. 2022 Jun 29;10:949425. doi: 10.3389/fpubh.2022.949425. PMID: 35844842; PMCID: PMC9276960.
  6. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses. 2019 Jan 14;11(1):59. doi: 10.3390/v11010059. PMID: 30646565; PMCID: PMC6357155.
  7. Mavian C, Dulcey M, Munoz O, Salemi M, Vittor AY, Capua I. Islands as Hotspots for Emerging Mosquito-Borne Viruses: A One-Health Perspective. Viruses. 2018 Dec 25;11(1):11. doi: 10.3390/v11010011. PMID: 30585228; PMCID: PMC6356932.
  8. Graham BS, Mascola JR, Fauci AS. Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. JAMA. 2018 Apr 10;319(14):1431-1432. doi: 10.1001/jama.2018.0345. PMID: 29566112.
  9. Ahmad A, Eze K, Noulin N, Horvathova V, Murray B, Baillet M, Grey L, Mori J, Adda N. EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge. N Engl J Med. 2022 Feb 17;386(7):655-666. doi: 10.1056/NEJMoa2108903. PMID: 35172056.

Top Experts on “viral infections